Marshall Wace, LLP Clear Point Neuro, Inc. Transaction History
Marshall Wace, LLP
- $81.7 Billion
- Q2 2025
Shares
11 transactions
Others Institutions Holding CLPT
# of Institutions
104Shares Held
7.94MCall Options Held
98.8KPut Options Held
46.8K-
Vanguard Group Inc Valley Forge, PA1.48MShares$15.5 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA625KShares$6.59 Million0.0% of portfolio
-
Black Rock Inc. New York, NY366KShares$3.86 Million0.0% of portfolio
-
State Street Corp Boston, MA333KShares$3.51 Million0.0% of portfolio
-
Morgan Stanley New York, NY332KShares$3.5 Million0.0% of portfolio
About ClearPoint Neuro, Inc.
- Ticker CLPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,488,300
- Market Cap $258M
- Description
- ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...